Normal view MARC view ISBD view

Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy.

Mullin, Kathleen

Potential for treatment benefit of small molecule CGRP receptor antagonist plus monoclonal antibody in migraine therapy. [electronic resource] - Neurology 05 2020 - e2121-e2125 p. digital

Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't

ISSN: 1526-632X

Standard No.: 10.1212/WNL.0000000000008944 doi

Subjects--Topical Terms:
Adult
Analgesics--therapeutic use
Antibodies, Monoclonal--pharmacology
Antibodies, Monoclonal, Humanized--pharmacology
Calcitonin Gene-Related Peptide
Calcitonin Gene-Related Peptide Receptor Antagonists--pharmacology
Female
Humans
Migraine Disorders--drug therapy
Receptors, Calcitonin Gene-Related Peptide--drug effects

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)